Hematological investigations in a case of intravascular hemolysis due to infection

Anamarija Beljan,Viktorija Blagec,Ana Bronic,Marina Pavi

DOI: https://doi.org/10.11613/bm.2024.021001

2024-04-17

Biochemia Medica

Abstract:Preanalytical mysteries by Anamarija Beljan, Viktorija Blagec, Ana Bronic, Marina Pavić

medical laboratory technology

What problem does this paper attempt to address?

Nosocomial Infections in Patients with Hematopathy:An Investigation of Causes and Countermeasures

HE Hong,GU Ping,DING Zuo-feng

2010-01-01

Abstract:OBJECTIVE To analyze the causes of nosocomial infections in patients with hematopathy and explore the countermeasures to control infections.METHODS The retrospective analysis of nosocomial infections was performed before and after the removal of wards of hematology internal medicine in 2008.RESULTS The case-time rates of nosocomial infections before and after the removal of wards were 18.38%and 8.80%,respectively.The difference between the two rates was statistically significant(χ2=15.7845,P<0.001).CONCLUSION The rates of nosocomial infections before and after the removal of wards are closely related to both hospital environment and implementation of correlatively protective isolation measures.
The Influence of Different Peripheral Venous Blood Sampling Methods on Hemolysis Rate in Emergency Room

WANG Jin,JIN Jing-fen

DOI: https://doi.org/10.3761/j.issn.0254-1769.2011.09.002

2011-01-01

Abstract:Objective To compare the influence of three different peripheral venous blood sampling methods on hemolysis rate.Methods A total of 1036 patients who needed both intravenous infusion and venous blood sampling were randomized to three groups receiving different blood sampling methods:obtaining the blood samples through the intravenous catheter connected with the vacutainer(group A,n=343),obtaining the blood samples through the intravenous catheter connected with the syringe(group B,n=365),and obtaining the blood samples through the vacutainer system(group C,n=328).The rates and degree of hemolysis was recorded.Results The hemolysis rates among the three groups were significantly different(P0.05),which were 14.72 percent,25.21 percent,and 3.50 percent in group A,B,and C,respectively.The blood in the procoagulant inert separation tube(yellow cap) was more likely to hemolysis than that in the sodium citrate coagulation test tube(blue cap).The hemolysis rate of 18G,20G,and 22G intravenous catheters was 9.32 percent,19.81 percent,and 32.58 percent,respectively.Conclusions The hemolysis rate of blood obtained though the vacutainer system is the lowest,and the hemolysis rate of blood obtained though the intravenous catheter connected with the syringe is the highest.
Preanalytical Errors in Hematology: Insights From a Tertiary Care Hospital

Vallal Kani,Kavitha Kannan,Sumithra Arumugam,Sulochana Sonti

DOI: https://doi.org/10.7759/cureus.69641

2024-09-18

Cureus

Abstract:Introduction Errors occur in the laboratory at any level of the testing process. Recognizing these errors may cause patient distress by delaying diagnosis and management until results are released. This study aims to assess preanalytical errors in the laboratory and suggests methods to prevent them to improve accuracy and efficiency in the hematology department of a tertiary care hospital. The background emphasizes the critical role of preanalytical procedures in ensuring accurate hematological diagnoses and highlights the frequent mistakes that occur during specimen collection, handling, and transportation. Staff training, process standardization, using suitable collecting and transport equipment, putting quality control measures in place, and using automation technologies are some strategies for reducing errors and speeding up turnaround times. To increase diagnostic accuracy, patient care outcomes, and laboratory efficiency, hematology laboratories should address preanalytical mistakes and employ fostering methods. Aims and objectives The objective of this research is to evaluate the frequency and characteristics of preanalytical errors within the hematology laboratory of a tertiary care hospital. The study seeks to gauge the scope of the problem, identify key factors contributing to these errors, such as issues in specimen collection, handling, and transportation, and highlight areas where improvements can be made. Also, it intends to assess how preanalytical errors affect hematological accuracy and turnaround times, with a focus on patient care outcomes, and recommend techniques to reduce preanalytical errors and improve the accuracy of hematological results. Materials and methods This study was conducted at the hematology laboratory of our hospital from January 2023 to June 2024 after getting proper approval from the Institutional Review Board (IRB approval number 294/08/2024/PG/SRB/SMCH). It is a retrospective analytical study, and the study population comprised samples of patients from the emergency, inpatient, and outpatient departments, which included 51,155 complete blood count (CBC) and 5,449 peripheral smear (PS) samples. The study included only test samples sent specifically for hematological analysis, while those sent for cytological, biochemical, or microbiological testing were excluded. The distribution frequency of the samples and the number of rejected samples were analyzed, and the results were then compared and correlated. Results During the study period, a total of 56,604 samples were processed in the hematology laboratory. Of these, 886 samples (1.3%) were rejected due to preanalytical errors. The most frequent error was submitting an insufficient sample (54.17%), while the least frequent was the use of an empty or defective tube (0.4%). In the emergency department, the primary issues were insufficient and clotted samples, while in pediatric cases, errors were mainly due to inadequate or diluted samples. Conclusion Preanalytical errors in hematology laboratories, though often overlooked, can significantly impact diagnostic accuracy and patient care. Our study highlights that a substantial portion of errors arise from inadequate sample collection and handling, particularly in emergency and pediatric cases. Adherence to standard laboratory techniques can dramatically reduce preanalytical errors.
Laboratory testing of extravascular body fluids in Croatia: a survey of the Working group for extravascular body fluids of the Croatian Society of Medical Biochemistry and Laboratory Medicine

Lara Milevoj Kopčinović,Željka Vogrinc,Irena Kocijan,Jelena Culej,Merica Aralica,Anja Jokić,Dragana Antončić,Marija Božović

DOI: https://doi.org/10.11613/BM.2016.042

2019-10-07

Biochemia Medica

Abstract:Original Papers by Lara Milevoj Kopcinovic, Zeljka Vogrinc, Irena Kocijan, Jelena Culej, Merica Aralica, Anja Jokic, Dragana Antoncic, Marija Bozovic

medical laboratory technology
Preanalytical Issues in Hemostasis and Thrombosis Testing

Giuseppe Lippi,Emmanuel J. Favaloro

DOI: https://doi.org/10.1007/978-1-4939-7196-1_2

2017-01-01

Abstract:Hemostasis testing is critical to many hemorrhagic and thrombotic disorders, wherein laboratory diagnostics can provide critical information for diagnosis, prognostication, and therapeutic monitoring. Due to this crucial role in modern medicine, hemostasis tests should be carried out at their highest degree of quality, thus encompassing standardization and monitoring of all phases of the testing process. It is now clearly established that the preanalytical phase is the most critical and vulnerable part of the total testing process, since up to 70% of diagnostic errors are due to highly manual activities encompassing patient preparation and collection of biological samples, as well as handling, transportation, preparation and storage of blood specimens. Due to the peculiar sample matrix required for hemostasis testing (i.e., plasma anticoagulated with buffered sodium citrate), additional critical issues may impair the reliability of these tests. Therefore, this article aims to provide an updated overview of the most important preanalytical variables that may ultimately impair the quality of hemostasis and thrombosis testing.
Policies and practices in the field of laboratory hematology in Croatia – a current overview and call for improvement

Vanja Radišić Biljak,Ivana Lapić,Valentina Vidranski,Ivona Herceg,Franciska Tomić,Brankica Šimac,Martina Horvat,Helena Čičak,Dora Vuljanić,Adrijana Dorotić,Ana Nikler

DOI: https://doi.org/10.1515/cclm-2021-1027

2021-12-01

Clinical Chemistry and Laboratory Medicine (CCLM)

Abstract:Abstract Objectives In 2019 The Croatian Working Group for Laboratory Hematology, on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine, wanted to explore the background in field of laboratory hematology routine practice among Croatian laboratories in order to develop future strategies for producing national recommendations, if needed. Methods During April and May 2019, a comprehensive survey covering all main parts of the total testing process within the field of laboratory hematology among Croatian medical laboratories was conducted. The survey comprised 49 inquiries. Data was collected using Survey Monkey (Palo Alto, CA, USA). All collected data was anonymized. Results The response rate was 72%. There is still a substantial number of laboratories that have only three-part differential hematology analyzers (9%). Furthermore, a very high number of laboratories did not perform analyzer verification prior to implementation into routine work (31%). Out of those who have verified their analyzers, a diversity of guidelines and recommendations were used. Nearly 10% of the laboratories do not have a defined policy regarding specimen rejection. The majority of the participants perform internal quality control daily (83%), however, only 51% of respondents evaluate the agreement between different hematology analyzers on daily basis. Although more than 90% of Croatian laboratories have a defined policy regarding specimen rejection, only 61% of respondents continuously monitor quality indicators in routine practice. Conclusions The survey revealed substantial differences in all aspects of laboratory hematology practices among Croatian medical laboratories, indicating the need for universal recommendations at the national level.
Causes, consequences and management of sample hemolysis in the clinical laboratory

Laura Heireman,Pieter Van Geel,Lorenz Musger,Evelien Heylen,Wim Uyttenbroeck,Boris Mahieu

DOI: https://doi.org/10.1016/j.clinbiochem.2017.09.013

Abstract:Preanalytical hemolysis of blood samples is a common problem in medical practice, especially in emergency departments. Several potential influences on sample hemolysis have been investigated, including sampling techniques, centrifugation and sample transport. In particular, the use of intravenous catheters and the vacuum sampling technique have often been demonstrated to provoke hemolysis. Other factors playing a role include the use of inappropriate puncture sites, complicated blood sampling, prolonged tourniquet application, underfilling of tubes and excessive shaking of specimens. Training of phlebotomists can play a pivotal role in overcoming these issues. A sample may also undergo hemolysis at the point of centrifugation, more specifically when centrifugation lasts too long or is done repeatedly. Pneumatic tube system (PTS)-transported samples tend to be more strongly affected by hemolysis compared to hand-carried ones, though whether this difference is clinically relevant remains questionable. The velocity at which the sample moves, the distance it covers and the shock forces it sustains all determine to what extent hemolysis occurs during PTS transport. The use of cushion inserts in the carrier to stabilize the samples and the presence of a gel separator in the transported serum tubes may prevent PTS-induced hemolysis. Finally, there is considerable variation between patients in the extent to which samples are prone to hemolysis. Sample hemolysis leads to unreliable laboratory results, delayed diagnosis and patients suffering avoidable discomfort. Specifically, hemolysis may interfere with laboratory results due to release of intracellular components, dilution effects, proteolysis and interference with analytical techniques. There is ongoing debate about how laboratories should deal with results altered by hemolysis. Laboratory specialists should clearly communicate with the ordering clinicians in order to make an informed decision about how to interpret hemolysis-affected analytical results. This review looks into current evidence concerning the causes and consequences of in vitro hemolysis, and aims to explain how to deal with it.
Cherry-red plasma: Beyond the assumption of hemolysis

Lechuang Chen,Yu Zhang,Qing H Meng

DOI: https://doi.org/10.1016/j.cca.2024.119917

2025-01-01

Abstract:Hemolysis is the most prevalent pre-analytical interfering factor and a major source of error in laboratory analysis. The examination of samples post-centrifugation can provide valuable information regarding pre-analytical interferences. In this unusual case, a patient's plasma specimen was cherry-red after centrifugation, which is most usually indicative of hemolysis. However, subsequent investigations ruled out common hemolysis causes. We eventually determined that the patient's cherry-red plasma was most likely caused by other factors in the patient's medical history, including cancer treatment with PV-10 (rose bengal disodium 10%). We then conducted an interference study to comprehensively assess the effects of PV-10 on various biochemical tests, especially liver function tests and bilirubin levels. The findings indicate that PV-10 has varying effects on different biochemical assays and test results should be examined individually. This report underlines the need for awareness of potential drug interference on laboratory tests for better result interpretation and making clinical decisions.
Blood Transfusion Procedure: Assessment of Serbian Intensive Care Nurses' Knowledge

Dragana Simin,Vladimir Dolinaj,Branislava Brestovački Svitlica,Jasmina Grujić,Dragana Živković,Dragana Milutinović

DOI: https://doi.org/10.3390/healthcare12070720

2024-03-26

Health Care

Abstract:Many patients require administering one or more blood components during hospitalisation in the Intensive Care Unit (ICU). Therefore, nurses' knowledge of who is responsible for immediately administering blood transfusions, monitoring patients, and identifying and managing transfusion reactions is crucial. This cross-sectional descriptive-analytical study aimed to assess the knowledge of ICU nurses in tertiary healthcare institutions about blood transfusion procedures. The questionnaire about the transfusion procedure was designed and reviewed by experts. The questionnaire consisted of 29 items divided into three domains. The scores on the knowledge test ranged from 10 to 27. Generally, 57.7% of nurses had moderate, 23.4% low, and 18.9% high levels of knowledge about the transfusion procedure. Most nurses answered correctly about refreezing fresh frozen plasma, verifying the transfusion product, and identifying the patient. Of the nurses, 91.0% would recognise mild allergic reactions, and 98.2% knew about the supervision of sedated patients. Nurses showed poor knowledge of the length of usage of the same transfusion system for red blood cells, labelling, and transfusion administration in febrile patients. Nurses with higher education and longer working experience had significantly better outcomes (p = 0.000) on the knowledge test. Continuous education of ICU nurses on safe transfusion usage is recommended.

health care sciences & services,health policy & services
Immunohematological provision of red blood cells transfusions to alloimmunized recipients (clinical case)

A V Yovdiy,E V Butina,E A Poponina

DOI: https://doi.org/10.51620/0869-2084-2022-67-4-234-236

2022-04-17

Abstract:Timely diagnostics of red blood cells (RBC) antibodies and selection of immunologically compatible donors can prevent the occurrence of hemolytic transfusion reactions in recipients of RBC. The article presents an analysis of a clinical case describing the variability of the antibody screening results and the difficulties of individual selection of donors for a alloimmunized patient with myelodysplastic syndrome. The basic immunohematological principles have been formulated to ensure the safety of transfusions in patients with RBC antibodies.
Prevalence and identification of irregular erythrocyte antibodies in voluntary blood donors in the territory of southeast Serbia

Milica Randjelovic,Ana Velickovic,Jelena Vojinovic,Zoran Stanojkovic

DOI: https://doi.org/10.2298/vsp231105022r

2024-01-01

Vojnosanitetski pregled

Abstract:Background/Aim. The purpose of tests for transmittable diseases, as well as determining ABO group, Rh typing, and the presence of clinically significant erythrocyte antibodies, is to enable the appropriate selection of blood/blood components for transfusion, to prevent or minimize adverse effects of transfusion, and to identify donors whose units of blood/components are not suitable for transfusion. The aim of the study was to evaluate the presence of irregular erythrocyte antibodies as well as to determine the specificity and origin of these antibodies in voluntary donors. Methods. This prospective observational study, conducted from January until July 2023, included samples of voluntary blood donors (BDs) for antibody screening in the population of voluntary BDs in the territory of Southeast Serbia. A total of 23,082 samples from healthy BD were examined through this period. Results. The overall prevalence of irregular anti-erythrocyte antibodies was 0.1125%, with anti-K, anti-D, and anti-E being the most frequently identified alloantibodies. Out of a total of 26 donors with positive screening results, 11 (42.32%) had alloantibodies, and 15 (57.68%) had antibodies of undetermined specificity. A positive antibody test was observed more frequently in male donors, and the age range of 51 years and above accounted for the majority of positive cases. Conclusion. Immunohematological testing, including antibody screening in voluntary BDs, is important for safe blood transfusion and is of great clinical importance. Likewise, it reduces the risk of complications due to incompatible transfusions.

medicine, general & internal
Cell population data in venous thrombo-embolism and erysipelas: a potential diagnostic tool?

Yael Appelboom,Math P.G. Leers,Tom Schoenmakers,Daan J.L. van Twist

DOI: https://doi.org/10.1515/cclm-2024-1050

2024-10-26

Clinical Chemistry and Laboratory Medicine (CCLM)

Abstract:Research ethics: The research related to human use has complied with all the relevant national regulations, institutional policies, an in accordance with the tenets of the Helsinki Declaration and has been approved by the authors Institutional Review Board Medical Ethics Committee of Zuyderland Medical Centre (METCZ 20200210). Informed consent: Informed consent was waived due to the retrospective nature of this study. Author contributions: The authors have accepted responsibility for the entire content of this manuscript and approved its submission. Conflict of interest: The authors state no conflict of interest. Research funding: This project was partially funded by the Zuyderland Research and Innovation Fund. The funding organizations played no role in the study design; in the collection, analysis and interpretation of data; in writing of the report or in the decision to submit the report for publication. Data availability: Available on request. 1. Martens, RJ, van Adrichem, AJ, Mattheij, NJ, Brouwer, CG, van Twist, DJ, Broerse, JJ, et al.. Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer. Clin Chem Lab Med 2020;59:783–93. https://doi.org/10.1515/cclm-2020-1529. Search in Google Scholar PubMed 2. Boer, AK, Deneer, R, Maas, M, Ammerlaan, HS, van Balkom, RH, Thijssen, WA, et al.. Development and validation of an early warning score to identify COVID-19 in the emergency department based on routine laboratory tests: a multicentre case-control study. BMJ Open 2022;12:e059111. https://doi.org/10.1136/bmjopen-2021-059111. Search in Google Scholar PubMed PubMed Central 3. Linssen, J, Ermens, A, Berrevoets, M, Seghezzi, M, Previtali, G, van der Sar-van der Brugge, S, et al.. A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study. Elife 2020;26:e63195. https://doi.org/10.7554/elife.63195. Search in Google Scholar PubMed PubMed Central 4. Prodjosoewojo, S, Riswari, SF, Djauhari, H, Kosasih, H, van Pelt, LJ, Alisjahbana, B, et al.. A novel diagnostic algorithm equipped on an automated hematology analyzer to differentiate between common causes of febrile illness in Southeast Asia. PLoS Neglected Trop Dis 2019;13:e0007183. https://doi.org/10.1371/journal.pntd.0007183. Search in Google Scholar PubMed PubMed Central 5. Wypasek, E, Padjas, A, Szymańska, M, Plens, K, Siedlar, M, Undas, A. Non-classical and intermediate monocytes in patients following venous thromboembolism: Links with inflammation. Adv Clin Exp Med 2019;28:51–8. https://doi.org/10.17219/acem/76262. Search in Google Scholar PubMed 6. Hoffmann, J. Cell population data: much more to explore. CCLM 2022;61:377–9. https://doi.org/10.1515/cclm-2022-1173. Search in Google Scholar PubMed 7. Johnson, ED, Schell, JC, Rodgers, GM. The D-dimer assay. Am J Hematol 2019;94:833–9. https://doi.org/10.1002/ajh.25482. Search in Google Scholar PubMed This article contains supplementary material (https://doi.org/10.1515/cclm-2024-1050). © 2024 Walter de Gruyter GmbH, Berlin/Boston

medical laboratory technology
S3636 A Tricky Case of Ticks: Babesiosis Camouflaged as Gastrointestinal Bleeding

Rachel Patel,Salman Ahmed,Henry Lam,Michael Engels,Paola Blanco

DOI: https://doi.org/10.14309/01.ajg.0001043912.12390.98

2024-10-26

The American Journal of Gastroenterology

Abstract:Anemia is a common problem in clinical practice. Often, this is a result of blood loss from the gastrointestinal tract. Its prevalence among patients with Gastrointestinal (GI) bleeding has been estimated to be 61%. However, the differential for anemia is broad, and importantly, should include hemolytic processes. Here, we highlight a rare case of hemolytic anemia secondary to babesiosis masquerading as a GI bleed.

gastroenterology & hepatology
Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories

A. Magnette,M. Chatelain,B. Chatelain,H. Ten Cate,F. Mullier

DOI: https://doi.org/10.1186/s12959-016-0123-z

2016-12-01

Thrombosis Journal

Abstract:Ensuring quality has become a daily requirement in laboratories. In haemostasis, even more than in other disciplines of biology, quality is determined by a pre-analytical step that encompasses all procedures, starting with the formulation of the medical question, and includes patient preparation, sample collection, handling, transportation, processing, and storage until time of analysis. This step, based on a variety of manual activities, is the most vulnerable part of the total testing process and is a major component of the reliability and validity of results in haemostasis and constitutes the most important source of erroneous or un-interpretable results.Pre-analytical errors may occur throughout the testing process and arise from unsuitable, inappropriate or wrongly handled procedures. Problems may arise during the collection of blood specimens such as misidentification of the sample, use of inadequate devices or needles, incorrect order of draw, prolonged tourniquet placing, unsuccessful attempts to locate the vein, incorrect use of additive tubes, collection of unsuitable samples for quality or quantity, inappropriate mixing of a sample, etc. Some factors can alter the result of a sample constituent after collection during transportation, preparation and storage.Laboratory errors can often have serious adverse consequences. Lack of standardized procedures for sample collection accounts for most of the errors encountered within the total testing process. They can also have clinical consequences as well as a significant impact on patient care, especially those related to specialized tests as these are often considered as “diagnostic”. Controlling pre-analytical variables is critical since this has a direct influence on the quality of results and on their clinical reliability. The accurate standardization of the pre-analytical phase is of pivotal importance for achieving reliable results of coagulation tests and should reduce the side effects of the influence factors. This review is a summary of the most important recommendations regarding the importance of pre-analytical factors for coagulation testing and should be a tool to increase awareness about the importance of pre-analytical factors for coagulation testing.

peripheral vascular disease,hematology
Quality improvement project: Reducing non-conformities of the samples for haemostasis testing in a secondary healthcare centre through the nurses' education in phlebotomy

Patricija Banković Radovanović

DOI: https://doi.org/10.11613/BM.2020.020708

2020-06-15

Abstract:Introduction: Poor compliance to the current guidelines and lack of knowledge among nurses about proper blood sampling is set as the study hypothesis. Here is presented a quality improvement project with following aims: a) to identify the most prevalent non-conformity of the samples for haemostasis testing, b) to identify the cause of sample non-conformity, c) to perform corrective action(s) and d) to assess the effectiveness of the corrective action(s). Materials and methods: The rate of non-conformity of samples collected for haemostasis tests was established for hospital wards with inpatients. Phlebotomy practice was audited throughout anonymous questionnaire among hospital's nurses who perform phlebotomy. Education about blood sampling was performed as a 1-hour lecture in different small groups each working day within one month. Education effectiveness was assessed through the evaluation of sample quality and is considered effective if more than half of the hospital wards significantly reduced their sample non-conformities rate. Results: Clotted sample constituted 84% of sample non-conformities. The questionnaire revealed nurses' poor knowledge in phlebotomy. There was no difference in nurses' knowledge regarding the level of education or work experience. Reduction in sample non-conformities was observed in 7 out of 9 wards 4 months after education; this improvement was statistically significant for 5 wards. Conclusion: Clotted sample as the most prevalent non-conformity of the samples for haemostasis testing is caused by the lack of knowledge of the nurses in several parts of the phlebotomy process. Specific education of the motivated personnel in small groups was successful and long-term effective.
Influence of hemolysis on nucleated red blood cells count

Xiuli Cheng,Le Zhang,Haimiao Yu,Biao Zhang

DOI: https://doi.org/10.1111/ijlh.14039

Abstract:Introduction: Hemolysis is a common pre-analytical factor that can influence test results. Here, we explored the influence of hemolysis on nucleated red blood cells (NRBCs) count and tried to illustrate the mechanisms underlying this interference. Methods: From July 2019 to June 2021, 20 preanalytical hemolytic peripheral blood (PB) samples from inpatient at Tianjin Huanhu Hospital were evaluated using Sysmex XE-5000 automated hematology analyzer. When NRBC enumeration was positive and a flag was triggered, a 200-cell differential count was performed by experienced technologists on microscopic review. When the manual count was inconsistent with automated enumeration, samples will be re-collected. Plasma exchange test was performed to verify the influence factors of hemolyzed samples and the mechanical hemolysis experiment mimicking hemolysis that might occur during blood collection was performed to illustrate the underlying mechanisms. Results: Hemolysis led to false-positive NRBC count and the value of NRBC was positively correlated with the degree of hemolysis. Hemolysis specimen shared a common scatter diagram: a "beard" on WBC/ basophil (BASO) channel and a "blue scatter line" on immature myeloid information (IMI) channel. Lipid droplets were found above the hemolysis specimen after centrifugation. Plasma exchange experiment confirmed that these lipid droplets interfered with NRBCs count. Mechanical hemolysis experiment implied further that broken red blood cells (RBCs) released lipid droplets causing the false-positive NRBCs count. Conclusion: In the present study, we firstly found that hemolysis could lead to false-positive NRBCs enumeration, which was associated with lipid droplets released from broken RBCs during hemolysis.
Establishing the Approach to the Diagnosis of Hemolytic Anemia in the Genetic Era: A Case Series

Aayushi Guru,Pratibha Meena,G K Sawke,Sakshi Tripathi

DOI: https://doi.org/10.7759/cureus.67952

2024-08-27

Cureus

Abstract:Background: Hemolytic anemia is characterized by the premature destruction of red blood cells, a condition that ranges from chronic to life-threatening. Hereditary hemolytic anemias (HHAs) encompass a broad spectrum of disorders including hemoglobinopathies, enzymopathies, and membrane disorders. In India, hemoglobinopathies, notably thalassemia and sickle cell disease, are significant health concerns contributing to high morbidity and mortality rates. Despite many cases being clinically insignificant, these disorders exert a considerable public health burden due to their prevalence. Techniques like next-generation sequencing (NGS) and high-performance liquid chromatography (HPLC) have emerged as powerful tools for identifying and diagnosing HHAs. NGS enables comprehensive genetic analysis, pinpointing mutations associated with hemoglobinopathies and other forms of hereditary anemia. HPLC allows precise quantification and characterization of hemoglobin variants, which is crucial for diagnosing hemoglobinopathies. Aims and objectives: This study aimed to establish a refined approach for diagnosing hemolytic anemias and categorize different types of hemolytic anemia using state-of-the-art technologies for early and precise treatment interventions. Materials and methods: This retrospective study was conducted in the Hematology Section of the Department of Pathology at Atal Bihari Vajpayee Government Medical College, Vidisha, Madhya Pradesh. The study included six patients diagnosed with hemolytic anemia based on comprehensive hematological, biochemical, and molecular evaluations. Results: The retrospective analysis of six cases of hemolytic anemia highlighted the diagnostic approach utilized. Clinical presentations, physical examinations, routine hematological investigations, advanced diagnostic modalities, and hemoglobin electrophoresis were instrumental in identifying specific types of hemolytic anemias. Conclusion: Despite the availability of advanced diagnostic techniques, basic hematological investigations remain the cornerstone in the initial evaluation of HHAs. Hemoglobin electrophoresis plays a pivotal role in confirming diagnoses. In some cases, subtle hematological findings necessitate thorough evaluation, including familial studies, to guide appropriate management strategies.
POINT-OF-CARE DIAGNOSTIC APPROACH IN A CRITICALLY ILL PATIENT WITH SEVERE BLEEDING FROM URINARY TRACT

Sonja Škiljić,Nenad Nešković,Gordana Kristek,Marija Milić,Hrvoje Vinković,Karlo Kedačić,Slavica Kvolik

DOI: https://doi.org/10.20471/acc.2023.62.s2.20

Abstract:Coagulation disorders in critically ill patients presenting with bleeding can be multicausal. The drugs applied can interfere and impair the coagulation cascade. Point-of-care (POC) coagulation assays may resolve difficult therapeutic situations in critical illness. We report on a 73-year-old critically ill male patient with massive hematuria after bladder lithotripsy. The patient was on low molecular weight heparin therapy due to recent pulmonary embolism. He was subjected to repeated surgical hemostasis which was ineffective despite massive transfusion protocol and normal standard coagulation profile. Additional POC coagulation assays were obtained and were indicative of platelet dysfunction. We revised his medical therapy and suspected the possible drug influence on platelet aggregation. After discontinuation of target drug, platelet aggregation increased whereas hematuria stopped. Coagulation disorders in intensive care unit patients are often multifactorial. Standard laboratory tests are unreliable in complex refractory bleeding and may result in inappropriate therapeutic decisions. Stepwise approach with assessment of clinical parameters, present therapy, and a combination of POC coagulation tests is the key to optimal therapeutic management.
[Risk of hemolysis in blood sampling from peripheral intravenous catheter: a literature review]

Matteo Danielis

DOI: https://doi.org/10.7429/pi.2014.673166

Abstract:Scope: Hemolysis is one of the main factors that can damage a blood sample. The availability of an intravenous line already placed pushes many nurses to use this route for blood drawing, even if it is known that this technique is associated with an increased rate of hemolysis compared to blood sampling with a needle. The aim of this work is to identify interventions that reduce risk of hemolysis if the blood sample is from a peripheral IV catheter. Method: A review of relevant literature was conducted through the databases MEDLINE, CINAHL and Cochrane database of Systematic Reviews. Results: Fifteen studies were retrieved. Factors such as the material and the caliber of the IV catheter, the presence of obstructions, the anatomical site, the permanence of the tourniquet, the difficulty of positioning of the catheter, the volume of the tube used and the skills of the operator are decisive in the risk of hemolysis of the sample. In term of cost and preferences of the patient, the technique of blood sampling from a peripheral IV catheter is preferable. Conclusions: Sample collection through intravenous catheters is associated with significant higher risk of hemolysis. Take a sample of blood from a peripheral catheter to carry out an analysis and, at the same time, reduce the risk of hemolysis is possible if some precautions are followed.
Analysis of Hematological Profiles in Hepatitis B Patients; Understanding the Interplay Between Viral Infections and Blood Parameters

DOI: https://doi.org/10.33140/jnh.09.02.10

2024-04-30

Journal of Nursing & Healthcare

Abstract:Introduction: Hepatitis B virus (HBV) infection is a worldwide health concern, associated with heightened risks of liver failure, hepatic dysregulation, and hepatocellular carcinoma. Despite progress in developed nations, underdeveloped regions face challenges like increased chronic hepatitis B frequency, limited access to prevention measures, and insufficient infection control. This study explores the hematological profiles of individuals with HBV to enhance diagnostic, prognostic, and treatment strategies. Methodology: A cross-sectional study at Fauji Foundation Hospital analyzed 85 HBV-positive and 85 control individuals. Ethical approval was obtained, and HBV serological markers were assessed. Hematological parameters were measured using an automated analyzer, and NLR and PLR were calculated. Software for statistical analysis, SPSS version 26, was used. Results: Statistical analysis unveiled significant differences in key hematological parameters between hepatitis B virus (HBV) positive individuals and the control group. HBV-infected subjects exhibited lower white blood cell counts (7.75 x 10^9/L vs. 8.878 x 10^9/L, p = 0.013) and platelet counts (228.38 x 10^9/L vs. 264.34 x 10^9/L, p = 0.007), indicating potential impacts on immune response and coagulation. Moreover, the HBV group demonstrated an elevated neutrophil-to-lymphocyte ratio (NLR) (2.27 vs. 1.74, p = 0.0002) and platelet-to-lymphocyte ratio (PLR) (104.3 vs. 115.4, p = 0.039), indicative of a pro-inflammatory state. Lymphocyte percentages were significantly lower in the HBV group (26.756% vs. 32.535%, p = 0.0003), suggesting compromised immune function. These findings highlight the hematological impact of HBV infection, emphasizing its potential clinical implications for diagnosis and treatment strategies. Conclusion: This study illuminates the complex interaction between hepatitis B virus (HBV) infection and hematological parameters. The observed deviations in key blood markers underscore the impact of HBV on immune function and coagulation. Reduced platelet and white blood cell counts suggest heightened susceptibility to complications. Alterations in the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) highlight a pro-inflammatory state, offering valuable insights for prognosis. These findings, while contributing to diagnostic advancements, underscore the importance of considering hematological parameters in the comprehensive management of HBV-infected individuals. Despite study limitations, including restricted hospital access and potential biases, the results provide a foundation for refining diagnostic and therapeutic strategies, advancing our understanding of HBV-related pathophysiology.

Hematological investigations in a case of intravascular hemolysis due to infection

Nosocomial Infections in Patients with Hematopathy:An Investigation of Causes and Countermeasures

The Influence of Different Peripheral Venous Blood Sampling Methods on Hemolysis Rate in Emergency Room

Preanalytical Errors in Hematology: Insights From a Tertiary Care Hospital

Laboratory testing of extravascular body fluids in Croatia: a survey of the Working group for extravascular body fluids of the Croatian Society of Medical Biochemistry and Laboratory Medicine

Preanalytical Issues in Hemostasis and Thrombosis Testing

Policies and practices in the field of laboratory hematology in Croatia – a current overview and call for improvement

Causes, consequences and management of sample hemolysis in the clinical laboratory

Cherry-red plasma: Beyond the assumption of hemolysis

Blood Transfusion Procedure: Assessment of Serbian Intensive Care Nurses' Knowledge

Immunohematological provision of red blood cells transfusions to alloimmunized recipients (clinical case)

Prevalence and identification of irregular erythrocyte antibodies in voluntary blood donors in the territory of southeast Serbia

Cell population data in venous thrombo-embolism and erysipelas: a potential diagnostic tool?

S3636 A Tricky Case of Ticks: Babesiosis Camouflaged as Gastrointestinal Bleeding

Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories

Quality improvement project: Reducing non-conformities of the samples for haemostasis testing in a secondary healthcare centre through the nurses' education in phlebotomy

Influence of hemolysis on nucleated red blood cells count

Establishing the Approach to the Diagnosis of Hemolytic Anemia in the Genetic Era: A Case Series

POINT-OF-CARE DIAGNOSTIC APPROACH IN A CRITICALLY ILL PATIENT WITH SEVERE BLEEDING FROM URINARY TRACT

[Risk of hemolysis in blood sampling from peripheral intravenous catheter: a literature review]

Analysis of Hematological Profiles in Hepatitis B Patients; Understanding the Interplay Between Viral Infections and Blood Parameters